Evinacumab [CAS 1446419-85-7]
Partner: MedChemexpress LLC
| CAS No: | 1446419-85-7 |
| Applications: | Metabolism-sugar/lipid metabolism |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Evinacumab] |
| Purity: | 98.98 |
| Description: | Evinacumab (REGN1500) is a humanised anti-ANGPTL3 (angiopoietin-like protein 3) monoclonal antibody (IgG4 class antibody). Evinacumab reduces plasma lipids in dyslipidemic mice by blocking ANGPTL3. Evinacumab can be used in studies of homozygous familial hypercholesterolaemia (HoFH), refractory hypercholesterolaemia (both familial and non-familial) and severe hypertriglyceridaemia[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
